Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (DEFICIT)

v3.24.3
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (DEFICIT) - USD ($)
$ in Thousands
Preferred Stock
Convertible Preferred Stock
Preferred Stock
Series B preferred stock
Common Shares
Series B preferred stock
Common Shares
Convertible Promissory Note
Common Shares
Additional Paid-in Capital
Series B preferred stock
Additional Paid-in Capital
Convertible Promissory Note
Additional Paid-in Capital
Accumulated Deficit
Series B preferred stock
Convertible Promissory Note
Total
Balance at Dec. 31, 2022         $ 1     $ 226,324 $ (228,321)     $ (1,996)
Balance (in shares) at Dec. 31, 2022         4,750              
Stock-based compensation               499       499
Restricted stock awards cancelled (in shares)         0              
Issuance of common stock in connection with convertible securities             $ 708       $ 708  
Issuance of common stock in connection with convertible securities (In shares)       450                
Issuance of common stock in connection with warrant exercise               8,202       $ 8,202
Issuance of common stock in connection with warrant exercise (in shares)         5,723             5,705
Issuance of common stock and warrants, net of offering costs               1,271       $ 1,271
Issuance of common stock and warrants, net of offering costs (in shares)         9,470              
Net Income (Loss)                 (921)     (921)
Balance at Mar. 31, 2023         $ 1     237,004 (229,242)     7,763
Balance (in shares) at Mar. 31, 2023         20,393              
Balance at Dec. 31, 2022         $ 1     226,324 (228,321)     (1,996)
Balance (in shares) at Dec. 31, 2022         4,750              
Net Income (Loss)                       (12,358)
Balance at Sep. 30, 2023         $ 1     241,563 (240,679)     885
Balance (in shares) at Sep. 30, 2023         43,868              
Balance at Dec. 31, 2022         $ 1     226,324 (228,321)     (1,996)
Balance (in shares) at Dec. 31, 2022         4,750              
Balance at Dec. 31, 2023 $ 247       $ 1     241,884 (247,042)     (5,157) [1]
Balance (in shares) at Dec. 31, 2023 38,335       222,380              
Balance at Mar. 31, 2023         $ 1     237,004 (229,242)     7,763
Balance (in shares) at Mar. 31, 2023         20,393              
Stock-based compensation               481       481
Release of vested restricted common stock (in shares)         1              
Restricted stock awards cancelled (in shares)         (1)              
Issuance of common stock in connection with warrant exercise               1,895       1,895
Issuance of common stock in connection with warrant exercise (in shares)         9,908              
Issuance of common stock and warrants, net of offering costs               1,048       1,048
Issuance of common stock and warrants, net of offering costs (in shares)         5,040              
Net Income (Loss)                 (5,326)     (5,326)
Balance at Jun. 30, 2023         $ 1     240,428 (234,568)     5,861
Balance (in shares) at Jun. 30, 2023         35,341              
Stock-based compensation               518       518
Stock-based compensation (in shares)         5,127              
Issuance of common stock in connection with warrant exercise               617       617
Issuance of common stock in connection with warrant exercise (in shares)         3,400              
Net Income (Loss)                 (6,111)     (6,111)
Balance at Sep. 30, 2023         $ 1     241,563 (240,679)     885
Balance (in shares) at Sep. 30, 2023         43,868              
Balance at Dec. 31, 2023 $ 247       $ 1     241,884 (247,042)     (5,157) [1]
Balance (in shares) at Dec. 31, 2023 38,335       222,380              
Stock-based compensation               380       380
Stock-based compensation (in shares)         4              
Issuance of common stock in connection with convertible securities           $ 325       $ 325    
Issuance of common stock in connection with convertible securities (In shares)     8,038                  
Issuance of Series B preferred stock in connection with warrant exercise, net of discounts   $ 386                    
Issuance of Series B preferred stock in connection with warrant exercise, net of discounts (in shares) 29,322                      
Issuance of common stock in connection with conversion of Series B preferred stock   (325)                    
Issuance of common stock in connection with conversion of Series B preferred stock (in shares) (5,000)                      
Deemed dividend on conversion of Series B preferred for common stock and repurchase of Series B preferred stock   5,842       (5,842)       (5,842)    
Repurchase of Series B preferred stock and Series B preferred stock warrants   $ (6,266)       $ 824       $ 824    
Repurchase of Series B preferred stock and Series B preferred stock warrants (in shares) (62,657)                      
Issuance of common stock, pre-funded units and warrants, net of offering costs               4,210       4,210
Issuance of common stock, pre-funded units and warrants, net of offering costs (in shares)         1,442,518              
Issuance of common stock in connection with reverse split rounding-up for fractional shares (in shares)         84,255              
Net Income (Loss)                 2,707     2,707
Balance (Accounting Standards Update 2020-06) at Mar. 31, 2024 $ 116             (116)       (116)
Balance at Mar. 31, 2024         $ 1     241,665 (244,335)     (2,669)
Balance (in shares) at Mar. 31, 2024         1,757,195              
Balance at Dec. 31, 2023 $ 247       $ 1     241,884 (247,042)     (5,157) [1]
Balance (in shares) at Dec. 31, 2023 38,335       222,380              
Issuance of common stock to vendors                       600
Net Income (Loss)                       (45,050)
Balance at Sep. 30, 2024         $ 1     296,386 (292,092)     4,295
Balance (in shares) at Sep. 30, 2024         7,767,828              
Balance at Mar. 31, 2024         $ 1     241,665 (244,335)     (2,669)
Balance (in shares) at Mar. 31, 2024         1,757,195              
Stock-based compensation               241       241
Stock-based compensation (in shares)         255,915              
Release of vested restricted common stock (in shares)         1              
Conversion of liability warrants to equity warrants               41,851       41,851
Restricted stock awards cancelled (in shares)         (82)              
Issuance of common stock in connection with warrant exercise               556       556
Issuance of common stock in connection with warrant exercise (in shares)         441,822              
Issuance of common stock and warrants, net of offering costs               8,756       8,756
Issuance of common stock and warrants, net of offering costs (in shares)         2,466,583              
Issuance of common stock to vendors               360       360
Net Income (Loss)                 (42,665)     (42,665)
Balance at Jun. 30, 2024         $ 1     293,429 (287,000)     6,430
Balance (in shares) at Jun. 30, 2024         4,921,434              
Stock-based compensation               345       345
Stock-based compensation (in shares)         532,973              
Issuance of common stock in connection with warrant amendment (in shares)         887,356              
Restricted stock awards cancelled (in shares)         (3,859)              
Issuance of common stock to vendors               240       240
Issuance of common stock to vendors (in shares)         236,203              
Issuance of common stock in connection with warrant exercise               2,372       2,372
Issuance of common stock in connection with warrant exercise (in shares)         1,193,721              
Net Income (Loss)                 (5,092)     (5,092)
Balance at Sep. 30, 2024         $ 1     $ 296,386 $ (292,092)     $ 4,295
Balance (in shares) at Sep. 30, 2024         7,767,828              
[1] The condensed consolidated balance sheet as of December 31, 2023 was derived from the audited consolidated balance sheet as of that date.